Find a better route: Optimizing AI for more novel synthetic predictions

AI and machine learning models aid in retrosynthetic planning, but are limited by the training data they have seen. Read on to learn about ways to generate novel predictions by ensuring your data has the necessary diversity and quality to optimize key synthetic planning initiatives.

Newly disclosed drug candidates, a polymer film for power and energy-efficient water production: What you may have missed at the ACS meeting

For those who couldn’t make the trip to New Orleans for the 255th ACS National Meeting & Exposition, we’ve highlighted some of the most interesting new research with potential industry applications.

How are changes in consumer preferences for natural products driving market disruption?

Learn how changes in consumer preferences for natural products are driving disruption in the cosmetics industry.

The importance of leadership skills in the scientific workforce

Successful scientists must be able to convincingly explain their research, be able to differentiate themselves in a sea of funding applications and speak confidently about their research to other scientists and non-scientists. These skills are not always emphasized in the academic environment, but are necessary to establish and run a successful research team.

Agile, it's not just for tech teams anymore

Read on to see what key benefits CAS marketing is attributing to Agile less than one year in on our journey, as well as some lessons we have learned along the way that your teams may want to consider if they are embarking on or optimizing an Agile practice.

Descriptive analytics still deliver: A cosmetics case study

Analysis of public data resources provides valuable general insights on a particular market, region or technology area. However, when more specific, actionable conclusions are needed to drive the strategy of your organization, a custom analytics project can provide much deeper insights.

Global vaccine trends: R&D and market insights driving new opportunities

Vaccines save millions of lives each year. By providing large-scale protection against serious diseases, vaccination programs proved to be one of the greatest public health achievements of the 20th century. Thanks to the advent of recombinant DNA technology and advanced multivalent vaccines, coupled with the ground-breaking innovation of cancer vaccines, the scope of vaccines continues to expand.

Leveraging the biologics boom for your drug development pipeline

The recent explosive growth of the biologics sector looks set to continue and their therapeutic use is increasingly being recognized as a fourth major method in cancer therapy (alongside the well-established approaches of surgery, chemotherapy and radiotherapy). With their suitability for individualized treatment, biologics will also play a key role in the development of precision medicine, another major area of focus for researchers, healthcare providers, investors and pharmaceutical companies. To predict and fully leverage the potential of biologics, it is important to understand the intricacies of this complex market.

Top 5 COVID-19 vaccine questions answered